Letters
High risk groups are still not being vaccinated
BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7484.198 (Published 20 January 2005) Cite this as: BMJ 2005;330:198
- Adam R Winstock, area clinical director (Adam.Winstock@swsahs.nsw.gov.au)
- Drug Health Services, South Western Sydney Area Health Service, PO Box 39, Liverpool BC, NSW1871, Australia
EDITOR—Aggarwal and Ranjan highlighted the global burden of hepatitis B and say that vaccination is the mainstay of prevention.1 They also describe the vaccination's lifelong efficacy and cost effectiveness. With such a clear evidence base and the recognition that certain high risk groups—such as injecting drug users—must be …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.